CVIE - ETF AI Analysis
Top Page
Calvert International Responsible Index ETF (CVIE)
Rating:58Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, with meaningful exposure to Japan, the UK, the U.S., and several European and Asia-Pacific markets, which helps reduce reliance on any single economy.
Balanced Sector Mix
Holdings are spread across financials, industrials, technology, health care, consumer sectors, and more, which helps cushion the impact if one industry runs into trouble.
Competitive Expense Ratio
The fund’s relatively low expense ratio means less of your return is eaten up by fees compared with many actively managed international funds.
Negative Factors
Financial Sector Tilt
A large portion of the portfolio is in financial companies, which can make the fund more sensitive to changes in interest rates and banking conditions.
Mixed Performance Among Top Holdings
While some leading positions like ASML, Roche, Siemens, and Toyota have shown strong or steady gains, others such as AstraZeneca, Nestlé, Royal Bank of Canada, and SAP have been weaker, which can drag on overall results.
Limited U.S. Exposure
The fund has only a modest allocation to U.S. stocks, so investors heavily reliant on U.S. market strength may find its performance differs from broad global benchmarks that are more U.S.-focused.
CVIE vs. SPDR S&P 500 ETF (SPY)
AUM319.62M
RegionDeveloped Markets
Expense Ratio0.18%
Beta0.79
IssuerCalvert
Inception DateJan 30, 2023
Dividend Yield2.75%
Asset ClassEquity
Index TrackedCalvert International Responsible Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume25,519
30 Day Avg. Volume20,433
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
83.71Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering657
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CVIE Summary
Calvert International Responsible Index ETF (CVIE) is an international stock fund that follows the Calvert International Responsible Index, focusing on large, established companies outside the U.S. It invests in firms that meet environmental, social, and governance (ESG) standards across many countries and sectors. Well-known holdings include Nestlé, Toyota Motor, and AstraZeneca. Someone might invest in CVIE to get broad global diversification while aligning their money with responsible business practices. A key risk is that international stock prices can go up and down with global markets and currency swings, so your investment value may fluctuate.
How much will it cost me?The Calvert International Responsible Index ETF (CVIE) has an expense ratio of 0.18%, meaning you’ll pay $1.80 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?CVIE could benefit from growing global interest in ESG investing, as more investors prioritize companies with strong environmental, social, and governance practices. However, its focus on developed markets outside the U.S. may face challenges from economic slowdowns or regulatory changes in those regions, particularly in sectors like financials and industrials, which make up a significant portion of its holdings.
CVIE Top 10 Holdings
CVIE leans heavily on a mix of European health care and global financial giants, with ASML acting as a key engine thanks to its steadily rising momentum over the year. Drugmakers like Roche, AstraZeneca, and Novartis are also pulling their weight, giving the fund a solid health care backbone. Big banks such as HSBC, Royal Bank of Canada, and Mitsubishi UFJ are more of a slow-and-steady crew, supporting but not supercharging returns. Siemens has been a bit mixed lately, occasionally tapping the brakes. Overall, it’s a diversified developed-markets ex-U.S. play with no single stock dominating the story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.03% | $6.54M | €457.92B | 85.99% | 76 Outperform | |
| AstraZeneca | 1.22% | $3.93M | $300.81B | 24.33% | 80 Outperform | |
| Roche Holding AG | 1.20% | $3.86M | CHF263.94B | 22.97% | 73 Outperform | |
| HSBC Holdings | 1.15% | $3.71M | £218.61B | 50.15% | 80 Outperform | |
| Novartis AG | 1.15% | $3.69M | CHF230.74B | 25.88% | 80 Outperform | |
| Nestlé SA | 1.06% | $3.42M | CHF201.15B | 2.25% | 71 Outperform | |
| Royal Bank Of Canada | 0.93% | $3.01M | $230.52B | 48.27% | 75 Outperform | |
| Siemens | 0.87% | $2.79M | €173.95B | 0.16% | 74 Outperform | |
| Toyota Motor | 0.86% | $2.77M | ¥45.75T | 27.64% | 80 Outperform | |
| SAP SE | 0.84% | $2.69M | €188.37B | -31.61% | 66 Neutral |
CVIE Technical Analysis
Neutral
―
Price Trends
75.90
Negative
72.61
Positive
68.79
Positive
Market Momentum
-0.81
Positive
41.21
Neutral
16.33
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CVIE, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 76.93, equal to the 50-day MA of 75.90, and equal to the 200-day MA of 68.79, indicating a neutral trend. The MACD of -0.81 indicates Positive momentum. The RSI at 41.21 is Neutral, neither overbought nor oversold. The STOCH value of 16.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CVIE.
CVIE Peer Comparison
Comparison Results
Performance Comparison
CVIE
Calvert International Responsible Index ETF
73.96
15.72
26.99%
DFSI
Dimensional International Sustainability Core 1 ETF
―
―
―
SEIE
SEI Select International Equity ETF
―
―
―
TPIF
Timothy Plan International ETF
―
―
―
PTIN
Pacer Trendpilot International ETF
―
―
―
TLCI
Touchstone International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents